Trial Profile
Leuplin SR 11.25 mg for Injection Specified Drug-use Survey 'Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)'
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Takeda
- 16 Jun 2014 New trial record